Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSQP5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,729
Award facts
- Contract value 100% obligated
- $83,728.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83,728.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The delivery order was issued on December 15, 2025, with an ultimate completion date of January 7, 2026, and carries no set-aside designation, indicating the contractor won this award through unrestricted federal procurement competition. Performance will occur at the contractor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, establishes regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance across multiple therapeutic categories, including oncology treatments and specialty pharmaceuticals, positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSQP5?
SPE2DR26FSQP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FSQP5 worth?
The government has obligated $83,729 on SPE2DR26FSQP5.
Is contract SPE2DR26FSQP5 an order under another contract?
Yes. SPE2DR26FSQP5 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQP5 competed?
The extent of competition for SPE2DR26FSQP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award